Press Releases

September 24, 2019 at 4:30 PM EDT

Summary Toggle Rockwell Medical, Inc. 2019 Cantor Global Healthcare Presentation

WIXOM, Mich. , Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul , Chief Executive Officer, is scheduled to present at the 2019 Cantor Global Healthcare Conference as follows: Date: Wednesday,

PDF Version
September 5, 2019 at 4:30 PM EDT

Summary Toggle Rockwell Medical, Inc. Appoints Industry Veteran John P. McLaughlin to Board of Directors

WIXOM, Mich. , Sept. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESRD) and chronic kidney disease

PDF Version
August 28, 2019 at 4:30 PM EDT

Summary Toggle Rockwell Medical, Inc. to Present at Upcoming September Conferences

WIXOM, Mich. , Aug. 28, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul , Chief Executive Officer, is scheduled to present at two upcoming conferences as follows: Conference NewsMakers in the Biotech Industry

PDF Version
August 8, 2019 at 4:05 PM EDT

Summary Toggle Rockwell Medical, Inc. Reports Second Quarter 2019 Financial Results

– Company Records First Commercial Sales of Dialysate Triferic®; FDA Accepts New Drug Application for I.V. Triferic with PDUFA date of March 28, 2020 – WIXOM, Mich. , Aug. 08, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the "Company"), a biopharmaceutical

PDF Version
August 8, 2019 at 6:50 AM EDT

Summary Toggle Rockwell Medical, Inc. Announces Completion of Two Clinical Pharmacology Studies of TRIFERIC® in China

– Positive data suggests no ethnic difference in Triferic PK in Chinese subjects compared to U.S. subjects – – China studies indicate similar delivery of iron via dialysate as in U.S. studies – WIXOM, Mich. , Aug. 08, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc.

PDF Version
August 6, 2019 at 6:50 AM EDT

Summary Toggle Rockwell Medical, Inc. Announces Acceptance by FDA of New Drug Application for I.V. TRIFERIC®

–FDA establishes PDUFA date of March 28, 2020 for I.V. Triferic – WIXOM, Mich. , Aug. 06, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus

PDF Version
July 29, 2019 at 4:30 PM EDT

Summary Toggle Rockwell Medical, Inc. to Discuss Second Quarter 2019 Financial Results on August 8, 2019

WIXOM, Mich. , July 29, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 second quarter financial results on Thursday, August 8, 2019 , after the close of the U.S. financial markets.

PDF Version
June 18, 2019 at 8:00 AM EDT

Summary Toggle Rockwell Medical Announces Pricing of $17.5 Million Public Offering of Common Stock

WIXOM, Mich. , June 18, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESRD) and chronic kidney disease

PDF Version
June 17, 2019 at 4:01 PM EDT

Summary Toggle Rockwell Medical Announces Proposed Public Offering of Common Stock

WIXOM, Mich. , June 17, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESRD) and chronic kidney disease

PDF Version
June 7, 2019 at 6:50 AM EDT

Summary Toggle Rockwell Medical Announces Adjournment of Annual Meeting of Shareholders

- Adjournment solely to vote on Delaware reincorporation Proposal 3(a) - - Both leading independent advisory firms have issued favorable recommendations on proposal - WIXOM, Mich. , June 07, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a

PDF Version